Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Minority Interest (2020 - 2026)

Apyx Medical filings provide 6 years of Minority Interest readings, the most recent being $291000.0 for Q4 2025.

  • On a quarterly basis, Minority Interest rose 132.8% to $291000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $291000.0, a 132.8% increase, with the full-year FY2025 number at $291000.0, up 132.8% from a year prior.
  • Minority Interest hit $291000.0 in Q4 2025 for Apyx Medical, up from $232000.0 in the prior quarter.
  • In the past five years, Minority Interest ranged from a high of $338000.0 in Q2 2021 to a low of $125000.0 in Q4 2024.
  • Median Minority Interest over the past 5 years was $220000.0 (2022), compared with a mean of $221950.0.
  • Biggest five-year swings in Minority Interest: crashed 47.21% in 2023 and later soared 132.8% in 2025.
  • Apyx Medical's Minority Interest stood at $317000.0 in 2021, then tumbled by 30.91% to $219000.0 in 2022, then increased by 0.91% to $221000.0 in 2023, then plummeted by 43.44% to $125000.0 in 2024, then skyrocketed by 132.8% to $291000.0 in 2025.
  • The last three reported values for Minority Interest were $291000.0 (Q4 2025), $232000.0 (Q3 2025), and $203000.0 (Q2 2025) per Business Quant data.